PHIO PHARMACEUTICALS CORP. APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
PHIO PHARMACEUTICALS CORP. (PHIO) reported APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition of $6.50 thousand for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition · last filed 2015-08-12
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2015-06-30 was $6.50K, a 1.52% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2015-03-31 was $6.50K, a 1.52% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2014-06-30 was $6.60K.
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2014-03-31 was $6.60K.
| Period end | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 6 month |
|---|---|---|
| 2015-06-30 | $6.50K 10-Q · filed 2015-08-12 | $13.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $6.50K 10-Q · filed 2015-05-13 | |
| 2014-06-30 | $6.60K 10-Q · filed 2015-08-12 | $13.20K 10-Q · filed 2015-08-12 |
| 2014-03-31 | $6.60K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |